Urodynamic outcomes after pelvic nerve-sparing radical hysterectomy with or without neoadjuvant chemotherapy
Metrics: PDF 854 views | Full Text 1305 views | ?
Satoshi Tsunetoh1, Yoshito Terai4, Masaaki Takai1, Satoe Fujiwara1, Yoshimichi Tanaka1, Tomohito Tanaka1, Hiroshi Sasaki1, Naokazu Ibuki2, Takanobu Ubai5, Kazuhiro Yamamoto3, Haruhito Azuma2 and Masahide Ohmichi1
1 Department of Obstetrics and Gynecology, Osaka Medical College, Takatsuki, Japan
2 Department of Urology, Osaka Medical College, Takatsuki, Japan
3 Department of Radiology, Osaka Medical College, Takatsuki, Japan
4 Department of Obstetrics and Gynecology, Kobe University, Kobe, Japan
5 Department of Urology, Takatsuki General Hospital, Takatsuki, Japan
|Satoshi Tsunetoh,||email:||[email protected]|
Keywords: uterine cervical cancer; nerve-sparing radical hysterectomy (NSRH); urodynamic study; neoadjuvant chemotherapy; balloon-occluded arterial infusion (BOAI)
Received: February 15, 2019 Accepted: July 29, 2019 Published: August 27, 2019
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.